Inventor · disambiguated record
Luca Arista
Also filed as: ARISTA LUCA
14 granted patents·15 pending applications·35 citations·filing 2001–2023
89Inventor score
Files withNOVARTIS AG11GLAXO GROUP LTD6BLACK DIAMOND THERAPEUTICS INC4ARISTA LUCA3ALIHODZIC SULEJMAN2
Top patents by PatentIndex Score
29 records- 0194US10947218B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2020·Granted Mar 16, 2021·6 cites·13 claims
- 0291US10710980B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·8 cites·6 claims
- 0387US7855298B2Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptorsGLAXO GROUP LTD·Filed 2005·Granted Dec 21, 2010·11 cites·12 claims
- 0485US11034672B1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·2 cites·29 claims
- 0583US11541056B23-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivativesNOVARTIS AG·Filed 2019·Granted Jan 3, 2023·2 cites·13 claims
- 0676US12441733B2Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitorsNOVARTIS AG·Filed 2023·Granted Oct 14, 2025·0 cites·12 claims
- 0773US11613543B2Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Mar 28, 2023·1 cites·14 claims
- 0873US7745458B2Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine D3 receptorsGLAXO GROUP LTD·Filed 2006·Granted Jun 29, 2010·2 cites·11 claims
- 0971US7790758B2Compounds which potentiate glutamate receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2006·Granted Sep 7, 2010·2 cites·15 claims
- 1070US12466808B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 1170US7807698B2Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptorGLAXO GROUP LTD·Filed 2006·Granted Oct 5, 2010·1 cites·5 claims
- 1270US2023398117A13-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide DerivativesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1359US8263782B2Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptorsARISTA LUCA·Filed 2009·Granted Sep 11, 2012·0 cites·22 claims
- 1458US2022363666A1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1556US12435046B2Alkynyl quinazoline compoundsBLACK DIAMOND THERAPEUTICS INC·Filed 2020·Granted Oct 7, 2025·0 cites·20 claims
- 1650US2024075042A1Method of treating cancers with alkyne substituted quinazoline derivativesBLACK DIAMOND THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1748US2022387602A1Bifunctional degraders and their methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1847US2009192194A1Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing ThemALVARO GIUSEPPE·Filed 2007·Application pending·0 cites
- 1946US2006211636A1Macrolide AntibioticsALIHODZIC SULEJMAN·Filed 2006·Application pending·0 cites
- 2045US2007073061A1Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing themGLAXO GROUP LTD·Filed 2004·Application pending·0 cites
- 2143US2005215495A1Macrolide antibioticsALIHODZIC SULEJMAN·Filed 2005·Application pending·0 cites
- 2242US2004077557A1Macrolide antibioticsFiled 2001·Application pending·0 cites
- 2341US2010048579A1Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonistsARISTA LUCA·Filed 2008·Application pending·0 cites
- 2440US2010261758A1Heterocyclic amides for use as pharmaceuticalsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 2539US2008139532A1Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents)GLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2637US11160797B2Pyridinone derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Nov 2, 2021·0 cites·18 claims
- 2735US2009326011A1Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulatorsARISTA LUCA·Filed 2006·Application pending·0 cites
- 2830US2017088546A1Carboxamide inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 2926US2017088545A1Carboxamide inhibitorsNORVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luca Arista files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →